✓ Betaling met creditcard hersteld — veilige afrekening via Privacy Shield

Rosuline

Rosuline is Torrent Pharma’s rosuvastatin 5/10 mg tablets — the most potent statin per mg. Originally AstraZeneca Crestor (2003). Hydrophilic, predominantly biliary clearance, minimal CYP3A4 metabolism — making it the preferred statin for patients on macrolides, azoles, or antiretrovirals. JUPITER (2008) extended statin indications to normal-LDL, high-hsCRP populations. HOPE-3 (2016) primary prevention in intermediate risk. Asian patients start at 5 mg (pharmacokinetic dose-cap).

Medisch beoordeeld door Morgan Ellis — Apotheekonderzoeker · 8 jaar ervaring  · Laatst beoordeeld: mei 2026

Meer kopen, meer besparen Prijs per tablet
Selecteer een sterkte hierboven om de verpakkingprijzen te zien.
Versleutelde checkout
Crypto betaalt 10% minder
Discrete wereldwijde levering
1.400+ klanten · 50+ landen

⚡ Quick Answer — What is Rosuline?

Rosuline is een 5 / 10 mg rosuvastatin tablet from Torrent Pharma — a high-intensity HMG-CoA reductase inhibitor (statin), hydrophilic. Statins reduce cardiovascular events by 20-30% per mmol/L LDL-cholesterol reduction across primary prevention, secondary prevention, diabetes, and post-stroke populations. Rosuvastatin was introduced by AstraZeneca in 2003 as Crestor. Hydrophilic statin; primarily excreted unchanged in faeces (10% renal, 90% biliary); minimal CYP metabolism (mostly CYP2C9 modestly). Dose range 5-40 mg once daily; 20-40 mg are high-intensity. Potency: rosuvastatin 20 mg reduces LDL-C by 52%; 40 mg by 55% — the most potent statin per mg. Typical dose: once daily, evening (for short-half-life statins) or any time for rosuvastatin (half-life long enough that timing does not matter). Main side effects: muscle symptoms (0.1-1% with confirmed CK elevation; up to 10% nocebo muscle aches), mild transaminase elevation (3%), new-onset diabetes in at-risk patients (~0.2 per 100 patient-years). Absolutely contraindicated in pregnancy, active liver disease, rhabdomyolysis history.

Wat u krijgt bij MedsBase: WHO-GMP gecertificeerde fabrikant · Discrete verpakking · Wereldwijde verzending · 1.400+ geverifieerde klantbeoordelingen

📦 Elke bestelling is gedekt door onze Reshipment Assurance Policy — als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.

Waarom bestellen bij MedsBase

Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen — geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor — nooit “MedsBase” of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.

What Is Rosuline?

Rosuline is an oral 5 / 10 mg rosuvastatin tablet from Torrent Pharma, supplied in 30-180 tablets. Rosuvastatin was introduced by AstraZeneca in 2003 as Crestor. Hydrophilic statin; primarily excreted unchanged in faeces (10% renal, 90% biliary); minimal CYP metabolism (mostly CYP2C9 modestly). Dose range 5-40 mg once daily; 20-40 mg are high-intensity.

How Rosuvastatin Works

Rosuvastatin inhibits HMG-CoA-reductase, the rate-limiting enzyme of hepatic cholesterol biosynthesis. Downstream:

  • Reduced intracellular cholesterol in hepatocytes — triggers sterol-regulatory element binding protein (SREBP) activation and upregulation of LDL-receptor expression on the hepatocyte surface
  • Increased clearance of circulating LDL-C — the primary LDL-lowering mechanism
  • Modest triglyceride reduction (10-20%) and modest HDL rise (5-10%)
  • Pleiotropic effects beyond LDL-lowering — reduced vascular inflammation (hs-CRP drop), improved endothelial function, plaque stabilisation, reduced platelet reactivity. The magnitude of the clinical benefit across trials exceeds what is explained by LDL-C change alone.

Rosuline Dosage

Primary prevention (no prior CV event): start 5-10 mg once daily; titrate to target based on 10-year ASCVD risk. For diabetics or ASCVD risk >7.5%, moderate-intensity (10-20 mg) is typical.

Secondary prevention (prior MI, stroke, PAD, or diabetic CVD): high-intensity therapy — 20-40 mg once daily. Target LDL-C <1.8 mmol/L (<70 mg/dL) per 2019 ESC and <1.4 mmol/L (<55 mg/dL) for very-high-risk ASCVD per 2021 ESC update.

Familial hypercholesterolaemia: maximum-tolerated statin (usually 40 mg) often combined with ezetimibe 10 mg and/or PCSK9 inhibitor (alirocumab/evolocumab/inclisiran) to achieve guideline targets.

Toediening: once daily with or without food. Any time of day — 19-hour half-life means timing does not meaningfully change efficacy.

Monitoring:

  • Uitgangswaarden: full lipid panel, LFTs (ALT), creatine kinase (CK), HbA1c or fasting glucose, creatinine, thyroid-stimulating hormone (TSH) if not recently checked.
  • 4-12 weken: repeat lipids to assess response. Expect rosuvastatin 20 mg reduces LDL-C by 52%; 40 mg by 55% — the most potent statin per mg. Dose-escalate if target not met.
  • Jaarlijks: lipids, LFTs (unless symptomatic). CK only on muscle complaints, not routinely.
  • Stop en onderzoek: CK >10× ULN, ALT >3× ULN and rising, persistent unexplained muscle pain with CK >5× ULN, rhabdomyolysis (dark urine, profound weakness).

Evidence for Rosuvastatin

JUPITER (2008) — rosuvastatin 20 mg in 17,802 patients with normal LDL but elevated hs-CRP reduced CV events by 44%; extended statin indications to “inflammation-driven” risk. ASTEROID (2006) — 40 mg for 24 months produced measurable coronary plaque regression on IVUS. SATURN (2011) — rosuvastatin 40 mg vs atorvastatin 80 mg; rosuvastatin slightly greater LDL reduction but no meaningful regression advantage. HOPE-3 (2016) — rosuvastatin 10 mg primary prevention in intermediate-risk patients reduced CV events by 24%.

Goedgekeurde en evidence-based toepassingen

  • Primary and secondary prevention of cardiovascular disease
  • Inflammation-driven risk with elevated hs-CRP (JUPITER)
  • Patients who are CYP3A4-interaction-prone (simpler pharmacology than atorvastatin)
  • Familiale hypercholesterolemie

Practical Considerations

Fewer CYP3A4 interactions than atorvastatin — a practical advantage when patients take macrolides, azoles, or certain antiretrovirals. Dose-capped in Asian patients — the FDA reduced the Asian starting dose to 5 mg after pharmacokinetic studies showed 2-fold higher plasma levels. Creatine kinase and LFT monitoring as for all statins.

Bijwerkingen

Vaak (>1%):

  • Myalgia (muscle pain) — bothersome in 5-10% of users; confirmed statin-associated muscle symptoms with CK rise in 0.1-1%. High nocebo component: SAMSON trial (2020) showed no difference between statin and placebo in double-blind n-of-1 crossovers in many “statin-intolerant” patients.
  • Lichte verhoging van transaminasen — 3% have ALT rise below 3× ULN; usually transient and does not require dose change.
  • New-onset diabetes — absolute excess ~0.2 per 100 patient-years, mostly in prediabetic patients. CV benefit far exceeds diabetes risk.
  • Headache, dyspepsia, nausea
  • Erectiestoornissen (uncommon; mechanism unclear)
  • Sleep disturbance, cognitive fog (reported but not consistent in RCTs)

Zeldzaam maar klinisch belangrijk:

  • Rhabdomyolyse (<1 per 10,000 patient-years) — severe muscle breakdown, renal failure risk. Stop immediately on dark urine + profound weakness + CK >10× ULN.
  • Immuungemedieerde necrotiserende myopathie — rare persistent myopathy that continues after stopping statin; anti-HMGCR antibody mediated. Needs immunosuppressive treatment.
  • Severe transaminitis / drug-induced liver injury — rare; stop if ALT >3× ULN with symptoms or rising trajectory.
  • Perifere neuropathie (zeldzaam)

Contra-indicaties

  • Zwangerschap en borstvoeding — statins are contraindicated; cholesterol is required for fetal neurodevelopment.
  • Actieve leverziekte or unexplained persistent ALT >3× ULN.
  • Prior rhabdomyolysis or severe statin-intolerance confirmed in double-blind rechallenge.
  • Concurrent strong CYP3A4 inhibitors (for rosuvastatin): clarithromycin, itraconazole, ritonavir — hold statin or switch to rosuvastatin/pravastatin.
  • Hypersensitivity to the statin.

Geneesmiddelinteracties

  • CYP2C9 and OATP1B1 transporter interactions — ciclosporin, gemfibrozil, and some antiretrovirals raise rosuvastatin levels. Dose-cap rosuvastatin at 5 mg with ciclosporin; avoid with gemfibrozil.
  • Grapefruitsap — minimal interaction with rosuvastatin (hydrophilic; minimal CYP3A4 metabolism).
  • Fibrates (gemfibrozil, fenofibrate) — additive myopathy risk. Gemfibrozil is the worst; fenofibrate is the preferred fibrate for combination. Reserve combinations for specialist dyslipidaemia care.
  • Niacin high-dose — additive myopathy risk. Low-dose niacin (1-2 g) usually tolerated.
  • Warfarine — small INR rise with statin initiation; check INR 1 week after starting. Not a contraindication.
  • Digoxine — small digoxin level rise with atorvastatin (P-glycoprotein); usually not clinically significant.
  • Alcohol — heavy intake raises liver injury risk. Moderate intake is acceptable.

Opslag

Store Rosuline below 25°C in the original blister pack. Keep out of reach of children.

Veelgestelde vragen

Do I have to take Rosuline at night?

No — rosuvastatin has a 19-hour half-life, long enough that the ~24-hour cycle of nocturnal cholesterol synthesis is covered regardless of dose timing. Morning dosing with other medications is fine. The “take statins at night” rule comes from short-half-life statins (simvastatin, lovastatin).

What if I get muscle aches on Rosuline?

Common and rarely dangerous. Check creatine kinase (CK). If CK is normal, the pains are usually not statin-related — the SAMSON trial (2020) showed most “statin-intolerant” patients had equal aches on placebo in double-blind crossover. Options: continue statin with vitamin D supplementation (if deficient), try coenzyme Q10 (weak evidence but low-risk), switch statin (rosuvastatin has lower muscle-symptom rate than simvastatin and atorvastatin in some trials), lower the dose, or adopt alternate-day dosing. Only stop if CK >10× ULN, symptoms are disabling, or there is objective weakness.

Will Rosuline give me diabetes?

Statins cause a small excess of new-onset diabetes — approximately 1 extra diabetes case per 1,000 people per year, mostly in those already at high diabetes risk (overweight, prediabetes, family history). The same treatment prevents roughly 5-10 cardiovascular events per 1,000 people per year in the same populations — so the net benefit is strongly positive. Do not stop a statin because of diabetes risk alone.

Can I take Rosuline with grapefruit juice?

Yes — rosuvastatin has minimal CYP3A4 metabolism, so the grapefruit interaction is minor. Contrast with atorvastatin where regular grapefruit consumption is discouraged.

How long will I need to take Rosuline?

Indefinitely, in almost all cases. Stopping a statin causes LDL-C to rebound within weeks and cardiovascular protection is lost within months. Statins are lifelong preventive therapy for atherosclerotic disease, not a short course.

Can I take Rosuline in pregnancy?

No — statins are contraindicated in pregnancy and breastfeeding. Cholesterol is required for fetal neurodevelopment; statins cross the placenta. Stop the statin before planned pregnancy; if pregnancy is unplanned, stop immediately and discuss risks with a specialist. Familial hypercholesterolaemia patients can usually safely defer statin therapy during pregnancy and breastfeeding.

Where can I buy Rosuline online?

You can buy Rosuline (rosuvastatin 5 / 10 mg, 30-180 tablets) from MedsBase with discreet packaging and worldwide shipping.

Gerelateerde hart- en hypertensiemedicijnen

⚕ Medisch disclaimer. Deze pagina is alleen voor informatieve doeleinden en vervangt geen medisch advies van een gekwalificeerde zorgverlener. Hypertensie, hartfalen en aritmieën vereisen diagnose, monitoring en doseringsindividualisatie door een arts — gebruik bètablokkers altijd onder medische begeleiding.

Waarom bestellen bij MedsBase

Rosuline is supplied through a WHO-GMP certified manufacturer with full COA documentation. We ship worldwide in plain, discreet packaging, and every order is covered by our Reshipment Assurance Policy. Uw betalingsbeschrijving bij betaling per kaart toont de gereguleerde betalingsverwerker (een gereguleerde kaartbetalingverwerker), nooit “MedsBase” of een medicijnnaam.

Gerelateerde alternatieven

Andere producten in Chronische aandoeningen die klanten ook bekijken:

Meer opties in behandelingen tegen hoog cholesterol

Gerangschikt op recente bestelvolumes van MedsBase — wat andere klanten in deze categorie kiezen.

Sterkte

5 mg, 10 mg

Hoeveelheid

30 Tabletten, 60 Tabletten, 90 Tabletten, 180 Tabletten

Beoordelingen

Er zijn nog geen beoordelingen

Plaats een beoordeling
Rosuline Rosuline
Beoordeling*
0/5
* Beoordeling is verplicht
* Antwoord is verplicht
Jouw beoordeling
* Beoordeling is verplicht
Naam
* Naam is verplicht
Voeg foto's of video toe aan je beoordeling

Vragen & antwoorden

Stel een vraag
Rosuline Rosuline
Uw vraag
* Vraag is verplicht
Naam
* Naam is verplicht
Er zijn nog geen vragen